Neutralizing antibody against severe acute respiratory syndrome (SARS)‐coronavirus spike is highly effective for the protection of mice in the murine SARS model

We evaluated the efficacy of three SARS vaccine candidates in a murine SARS model utilizing low‐virulence Pp and SARS‐CoV coinfection. Vaccinated mice were protected from severe respiratory disease in parallel with a low virus titer in the lungs and a high neutralizing antibody titer in the plasma....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Microbiol Immunol
Autors principals: Ishii, Koji, Hasegawa, Hideki, Nagata, Noriyo, Ami, Yasushi, Fukushi, Shuetsu, Taguchi, Fumihiro, Tsunetsugu‐Yokota, Yasuko
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Asia 2008
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7168451/
https://ncbi.nlm.nih.gov/pubmed/19291090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1348-0421.2008.00097.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars